Reducing Opioid Mortality in Illinois
Justice Community Opioid Innovation Network (JCOIN): Reducing Opioid Mortality in Illinois
University of Chicago
1,500 participants
Aug 10, 2021
INTERVENTIONAL
Conditions
Summary
Reducing Opioid Mortality in Illinois (ROMI) is 5-year research study led by the University of Chicago in partnership with the University of Illinois at Chicago's (UIC) Community Outreach Intervention Projects (COIP), the Illinois Criminal Justice Information Authority (ICJIA) and the American Institutes for Research (AIR). ROMI aims to understand and test strategies for linking individuals with a history of opioid use disorder who are released from Illinois jails and prisons to substance use treatment. ROMI is one of twelve grants awarded by the National Institutes of Health (NIH) as part of the Justice Community Opioid Innovation Network (JCOIN) to support research on quality addiction treatment for opioid use disorder in criminal justice settings nationwide.
Eligibility
Inclusion Criteria3
- Participants must be at least 18 years old
- Reside in designated research site county or zip code
- Satisfy criteria for likely OUD based upon nonmedical use of prescription opioids, heroin, or synthetic opioids.
Exclusion Criteria3
- Participants experiencing cognitive impairments that preclude informed consent.
- Reside out of the service area.
- Prior enrollment in a parallel JCOIN study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A blend between a Critical Time Intervention (CTI) case management model and a peer recovery coaching approach. CORI will employ peer-based case management/recovery coaching and other transitional services (e.g., peer navigation) to provide support and service linkages to medication-assisted treatment (MAT) and harm reduction interventions to reduce subsequent opioid use and related harms.
Participants will be trained on naloxone administration, and upon re-entry, they will be given a naloxone kit and information on local resources for harm reduction, SUD treatment, and additional supportive services.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04925427